Benzinga | Oct 19, 2020 11:13AM EDT

SVB Leerink Maintains Outperform on Agios Pharmaceuticals, Lowers Price Target to $67

SVB Leerink maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Outperform and lowers the price target from $72 to $67.